M. Sutton

Cardiovascular safety assessments in the conscious telemetered dog: utilisation of super-intervals to enhance statistical power.

S. Collins, M. Holbrook, N. Edmunds, 2010, Journal of pharmacological and toxicological methods.

Translation between in vitro inhibition of the cardiac Nav1.5 channel and pre-clinical and clinical QRS widening

Michael Engwall, Cheryl Li, J. Steidl-Nichols, 2009 .

Pyrimido[4,5-d]azepines as potent and selective 5-HT2C receptor agonists: design, synthesis, and evaluation of PF-3246799 as a treatment for urinary incontinence.

M. Andrews, A. Brown, P. Fish, 2011, Bioorganic & medicinal chemistry letters.

The hemodynamic properties of amlodipine in anesthetised and conscious dogs: Comparison with nitrendipine and influence of beta-adrenergic blockade

M. Sutton, M. Dodd, R. Burges, 1989, Cardiovascular Drugs and Therapy.

Effects of UK-68,798, a novel class III antiarrhythmic agent, in conscious dogs

P. Butler, M. Sutton, M. Dodd, 1989 .

Evidence for central α-adrenergic transmission in a cardio-inhibitory response from the rabbit hypothalamus

M. H. Evans, M. Sutton, N. M. Williamson, 1983, Neuropharmacology.